None
Test Name | SMN1 Gene Spinal muscular atrophy type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 1 |
Test Details |
The SMN1 gene is associated with spinal muscular atrophy (SMA) type 1, which is a genetic disorder that affects the muscles and motor neurons. SMA type 1 is the most severe form of the condition and typically manifests in infancy. NGS (Next-Generation Sequencing) is a high-throughput sequencing technology that can analyze multiple genes simultaneously. In the context of genetic testing for SMA type 1, NGS can be used to identify mutations or variations in the SMN1 gene that are associated with the condition. The NGS genetic test for SMA type 1 involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the SMN1 gene using NGS technology. The test can detect specific mutations or variations in the gene that are known to cause SMA type 1. The results of the NGS genetic test can help diagnose SMA type 1 and determine the specific genetic cause of the condition. This information is important for understanding the prognosis and potential treatment options for individuals with SMA type 1. |